Evidence map›Paper›PMID 32065790›Full record

ArticleJournal of Alzheimer's disease : JAD2020

How Accurately Do Patients and Their Care Partners Report Results of Amyloid-β PET Scans for Alzheimer's Disease Assessment?

Hailey J James, Courtney Harold Van Houtven, Steven Lippmann, James R Burke, Megan Shepherd-Banigan, Emmanuelle Belanger, Terrie Fox Wetle, Brenda L Plassman

Open access · greenAbstract read
In one paragraph

Article in Journal of Alzheimer's disease : JAD, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 2 pooled it
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 2 syntheses or guidelines pooled it, 22 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Counseling and disclosure practices in predictive Alzheimer's disease diagnostics: A scoping review.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2024
    Article
  7. Article
  8. "And Does That Necessarily Mean Absolutely Alzheimer's?" An Analysis of Questions Raised Following Amyloid PET Results Disclosure.The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry · 2024
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Hailey J JamesDepartment of Health Policy and Management, University of North Carolina, Chapel Hill, NC, USA.
Courtney Harold Van HoutvenDepartment of Population Health Sciences, Duke University, Durham, NC, USA.
Steven LippmannDepartment of Population Health Sciences, Duke University, Durham, NC, USA.
James R BurkeDepartment of Neurology, School of Medicine, Duke University, Durham, NC, USA.
Megan Shepherd-BaniganDepartment of Population Health Sciences, Duke University, Durham, NC, USA.
Emmanuelle BelangerCenter for Gerontology and Healthcare Research, School of Public Health, Brown University, Providence, RI, USA.
Terrie Fox WetleDepartment of Health Services, Policy and Practice, School of Public Health, Brown University, Providence, RI, USA.
Brenda L PlassmanDepartment of Neurology, School of Medicine, Duke University, Durham, NC, USA.
Duke University · USBrown University · USDurham VA Medical Center · USHealth Services Research & Development · US

Funding

Caregivers' Reactions and Experience: Imaging Dementia Evidence for Amyloid Scanning CARE IDEASR01AG053934 · NIA · BROWN UNIVERSITY · PI WETLE, TERRIE FOX · 2017 to 2020
$4.5M
Caregivers' Reactions and Experience: Imaging Dementia Evidence for Amyloid Scanning CARE IDEASR56AG053934 · NIA · BROWN UNIVERSITY · PI MOR, VINCENT · 2016 to 2016
$1.5M
NIA NIH HHS R01 AG053934NIA NIH HHS R56 AG053934
6 · The paper itself

Abstract

backgroundAmyloid-β PET scans will likely become an integral part of the diagnostic evaluation for Alzheimer's disease if Medicare approves reimbursement for the scans. However, little is known about patients' and their care partners' interpretation of scan results.

objectiveThis study seeks to understand how accurately patients with mild cognitive impairment (MCI) or dementia and their care partners report results of amyloid-β PET scans and factors related to correct reporting.

methodsA mixed-methods approach was used to analyze survey data from 1,845 patient-care partner dyads and responses to open-ended questions about interpretation of scan results from a sub-sample of 200 dyads.

resultsEighty-three percent of patients and 85% of care partners correctly reported amyloid-β PET scan results. Patients' higher cognitive function was associated with a small but significant decrease in the predicted probability of not only patients accurately reporting scan results (ME: -0.004, 95% CI: -0.007, -0.000), but also care partners accurately reporting scan results (ME: -0.006, 95% CI: -0.007, -0.001), as well as decreased concordance between patient and care partner reports (ME: -0.004, 95% CI: -0.007, -0.001). Content analysis of open-ended responses found that participants who reported the scan results incorrectly exhibited more confusion about diagnostic terminology than those who correctly reported the scan results.

conclusionOverall, patients with MCI or dementia showed high rates of accurate reporting of amyloid-β PET scan results. However, responses to questions about the meaning of the scan results highlight the need for improved provider communication, including providing written explanations and better prognostic information.

Indexed as

Amyloid beta-PeptidesAgedAged, 80 and overAlzheimer DiseaseCaregiversCognitive DysfunctionCohort StudiesFemaleHumansMaleMiddle AgedPatient ParticipationPositron-Emission TomographyAmyloid beta-PeptidesAlzheimer’s diseaseamyloid PETcaregiversdementiamild cognitive impairment

Identifiers

PMID32065790
PMCPMC7183243
OpenAlexW3006529262

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.